Is Afrezza in shortage in 2026? Get the latest update on Afrezza availability, pricing, pharmacy tips, and what to do if you can't find it.
If you rely on Afrezza for mealtime blood sugar control, you've probably experienced the frustration of hearing "we don't have that in stock" at your pharmacy. With so many patients reporting difficulty finding Afrezza, it's natural to wonder: is there an actual shortage?
In this article, we'll give you the latest update on Afrezza availability in 2026, explain why it's so hard to find, break down the current costs, and share practical steps to make sure you don't go without your medication.
As of early 2026, Afrezza is not listed on the FDA or ASHP drug shortage databases. This means there is no formal manufacturing shortage reported by MannKind Corporation, the sole manufacturer of Afrezza.
However, the real-world experience for many patients tells a different story. The reason? Afrezza's availability challenges are distribution-related, not production-related. MannKind is producing Afrezza, but many retail pharmacies simply don't stock it because of low local demand.
So while Afrezza is technically available through pharmaceutical wholesalers, getting it into your hands at a local pharmacy can still be a challenge. For a detailed breakdown of the reasons behind this, read our article on why Afrezza is so hard to find.
Several factors contribute to Afrezza's availability challenges in 2026:
Afrezza is made exclusively by MannKind Corporation. Unlike injectable rapid-acting insulins such as Humalog (Eli Lilly) and NovoLog (Novo Nordisk), which have generic and biosimilar versions from multiple manufacturers, Afrezza has no generic, no biosimilar, and no alternative supplier. If MannKind has any distribution hiccup, there's no backup.
Afrezza serves a relatively small patient population. Most pharmacy locations see only one or two Afrezza patients, if any. Chain pharmacies like CVS, Walgreens, and Rite Aid base their stocking decisions on local demand — so many locations simply don't keep it on the shelf.
Many insurance plans require prior authorization and sometimes step therapy (proving you've tried injectable insulins first) before covering Afrezza. This reduces the number of patients who end up filling Afrezza prescriptions, which further reduces pharmacy incentive to stock it.
Afrezza cartridges require proper storage — refrigeration for unopened cartridges, room temperature use within 10 days once opened, and inhaler replacement every 15 days. Some pharmacies are less inclined to stock products with specific handling requirements and a small customer base.
Afrezza remains a brand-name-only medication with no generic alternative, which means it carries a premium price:
For patients with commercial insurance, the Afrezza Savings Card can reduce your copay to as little as $35 per fill, with up to $2,000 in annual savings across 12 fills.
For cash-paying patients, the MannKind Direct Purchase Program offers Afrezza for as low as $99 per month, shipped to your door through Eagle Pharmacy.
Medicare patients benefit from the Inflation Reduction Act, which caps insulin copays at $35 per month under Part D (requires prior authorization).
For more ways to lower your costs, check out our full guide on how to save money on Afrezza.
While no new inhaled insulin competitors have entered the market as of 2026, there are some developments worth noting:
For a full comparison of alternatives, read our article on alternatives to Afrezza.
Here are the most effective strategies for getting your Afrezza prescription filled in 2026:
Medfinder lets you search for pharmacies near you that have Afrezza in stock. It's the fastest way to find availability without calling pharmacy after pharmacy.
Independent pharmacies and diabetes-focused specialty pharmacies are more likely to stock Afrezza or order it quickly for you. Ask your endocrinologist for recommendations.
Cash-paying patients can order Afrezza directly for $99/month through Eagle Pharmacy. Call 844-323-7399 or visit the Afrezza website.
Request refills at least 5-7 days before you run out. If your pharmacy needs to order Afrezza, this gives them enough time to get it from their wholesaler.
Check if your insurance offers mail-order pharmacy benefits for a 90-day supply — this can be both cheaper and more convenient than filling monthly at a retail pharmacy.
For detailed step-by-step guidance, read our full guide on how to find Afrezza in stock near you.
Afrezza is not in a formal shortage in 2026, but it remains harder to find than most insulins because of its single-manufacturer status, low pharmacy stocking rates, and insurance barriers. The situation can be frustrating, but there are real solutions available — from Medfinder's pharmacy search to MannKind's direct delivery program.
The most important thing is to plan ahead and know your options. Don't wait until you're out of cartridges to start looking. Use the tools and tips in this article to stay ahead of supply challenges and keep your diabetes management on track.
Start by searching for Afrezza availability at Medfinder.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
